Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Vasc Health Risk Manag ; 18: 567-574, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35903288

RESUMEN

Background: Chronic mesenteric ischemia (CMI) due to either atherosclerosis of the mesenteric arteries or median arcuate ligament syndrome (MALS) is an underdiagnosed entity. The etiology of MALS and its existence have been debated and questioned. We aimed to identify plasma biomarkers indicating mesenteric ischemia in patients with CMI and MALS. Methods: Plasma α-glutathione S-transferase (α-GST), intestinal fatty acid-binding protein (I-FABP), citrulline, and ischemia modified albumin (IMA) were analyzed in fifty-eight patients with CMI (Group A, n=44) and MALS (Group B, n=14) before and after revascularization. The plasma levels of these potential biomarkers were compared with those of healthy individuals (Group C, n=16). Group comparison was performed with the Mann-Whitney U-test. Cross-tabulation and its derivatives were obtained. Receiver operating characteristic (ROC) curves and area under the curve (AUC) were calculated. Results: Plasma levels of α-GST were significantly raised in the patients with CMI (7.8 ng/mL, p<0.001) and MALS (8.4 ng/mL, p<0.001), as compared with the control Group C (3.3 ng/mL). The threshold for normal median plasma α-GST levels of 4 ng/mL yielded a sensitivity of 93% and 86%, specificity of 86% and 88%, respectively, for the diagnosis of CMI due to atherosclerosis and MALS. AUC of ROC curves was 0.96 (p<0.0001) for CMI and 0.85 (p<0.002) for MALS. The patient groups did not differ from the healthy controls in any other biomarkers. Conclusion: Plasma α-GST levels are elevated in CMI and MALS patients. Elevated plasma levels of α-GST suggest ischemia as the etiology of MALS.


Asunto(s)
Aterosclerosis , Síndrome del Ligamento Arcuato Medio , Isquemia Mesentérica , Biomarcadores , Arteria Celíaca , Enfermedad Crónica , Glutatión Transferasa , Humanos , Isquemia , Síndrome del Ligamento Arcuato Medio/diagnóstico , Isquemia Mesentérica/diagnóstico por imagen , Albúmina Sérica
2.
Vasc Health Risk Manag ; 18: 233-243, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35431549

RESUMEN

Introduction: Due to diagnostic delay, chronic mesenteric ischemia (CMI) is underdiagnosed. We assumed that the patients suspected of CMI of the atherosclerotic origin or median arcuate ligament syndrome (MALS) could be identified earlier with endoscopic duplex ultrasound (E-DUS). Patients and Methods: Fifty CMI patients with CTA-verified stenosis of either ≥50% and ≥70% of celiac artery (CA) and superior mesenteric artery (SMA) were examined with E-DUS and transabdominal duplex ultrasound (TA-DUS). Peak systolic velocities (PSV) of ≥200cm/s and ≥275cm/s for CA and SMA, respectively, were compared with CTA. Subgroup analysis was performed for the patients with (n=21) and without (n=29) prior revascularization treatment of CMI. The diagnostic ability of E-DUS and TA-DUS was tested with crosstabulation analysis. Receiver operating characteristics (ROC) curve analysis was performed, and the area under the curve (AUC) was calculated to investigate the test accuracy. Results: In the patients with ≥70% stenosis, E-DUS had higher sensitivity than TA-DUS (91% vs 81% for CA and 100% vs 92% for SMA). AUC for SMA ≥70% in E-DUS was 0.75 and with TA-DUS 0.68. The sensitivity of E-DUS for CTA-verified stenosis ≥70% for CA was 100% in the patients without prior treatment. E-DUS demonstrated higher sensitivity than TA-DUS for both arteries with stenosis ≥50% and ≥70% in the treatment-naive patients. Conclusion: E-DUS is equally valid as TA-DUS for the investigation of CMI patients and should be used as an initial diagnostic tool for patients suspected of CMI.


Asunto(s)
Isquemia Mesentérica , Velocidad del Flujo Sanguíneo , Constricción Patológica , Diagnóstico Tardío , Humanos , Isquemia/diagnóstico por imagen , Isquemia/terapia , Isquemia Mesentérica/diagnóstico por imagen , Isquemia Mesentérica/terapia , Estudios Retrospectivos
3.
Vasc Health Risk Manag ; 18: 139-151, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35356549

RESUMEN

Background: The selection of patients with MALS for surgical treatment depends upon the reliability of the symptom interpretation and the diagnostic work-up. We aimed to follow up the results of the laparoscopic decompression of the patients with MALS. Patients and Methods: In a single-center, 52 consecutive MALS patients were followed-up, prospectively, after transperitoneal laparoscopic decompression. MALS was diagnosed with a computed tomography angiography (CTA) verified stenosis, ≥50% of the celiac artery (CA), and with duplex ultrasound, a peak systolic velocity (PSV) ≥2.0 m/s. Postoperative, CTA, and duplex ultrasound were performed, and the patients were followed-up at 3, 6, 12 months, and yearly after that. Results: Mean age of the patients was 47 ±21 years, and 65% were females. The patients had a mean weight loss of 8.4 ±7.2 kg. Fifty-one patients had the laparoscopic operation with a mean operation time of 102 ± 28 minutes. Forty-seven patients (90%) achieved relief from the symptoms either completely (67%) or partially (23%) at 3-6 months of follow-up. Significant improvement in postoperative PSV was found compared to the preoperative values, p<0.001. Five patients (10%) with no immediate effect of the operation, but two of them became free from symptoms during the mean study follow-up of 2.4 ± 2 years. Five patients (10%) had operative complications, including one trocar injury to the liver, one pneumothorax, and three cases of bleeding from the branches of CA. Two patients died of cancer disease during the study period. Only two patients (4%) had symptoms relapse, both later treated successfully. Conclusion: Laparoscopic transperitoneal decompression provides most of the patients a persistent relief from MALS symptoms.


Asunto(s)
Laparoscopía , Síndrome del Ligamento Arcuato Medio , Dolor Abdominal/complicaciones , Dolor Abdominal/cirugía , Adulto , Anciano , Descompresión Quirúrgica/efectos adversos , Descompresión Quirúrgica/métodos , Femenino , Humanos , Laparoscopía/efectos adversos , Masculino , Síndrome del Ligamento Arcuato Medio/diagnóstico por imagen , Síndrome del Ligamento Arcuato Medio/cirugía , Persona de Mediana Edad , Estudios Prospectivos , Reproducibilidad de los Resultados
4.
Vasc Health Risk Manag ; 18: 61-71, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35221689

RESUMEN

BACKGROUND: QoL assessment within surgical treatment is seldom investigated and sparsely reported in the medical literature. This study aimed to compare QoL in a randomized fashion in the patients treated with either a laparoscopic aortobifemoral bypass (LABFB) or an open aortobifemoral bypass (OABFB) for the treatment of AIOD. PATIENTS AND METHODS: Seventy-one consecutive patients with AIOD, Trans-Atlantic Inter-Society Consensus II Type D lesions (TASC II, Type D) were randomized to LABFB or OABFB. Thirty-five patients in the LABFB and thirty-six in the OABFB groups were compared for the changes in the QoL, with the short-form health survey (SF-36), EuroQol 5 dimensions (EQ-5D), and EQ-5D visual analog scale (VAS) preoperatively, and postoperatively at 1, 3, 6, 12 and 24 months. Mann-Whitney U-Test and Wilcoxon sign-rank test were used for group comparison. Mixed model analysis was performed to examine the effect of different variables on the QoL. RESULTS: In the patients treated with LABFB, physical component score (PCS) and mental component score (MCS) in SF-36 were significantly higher than OABFB, at 1 and 3 months postoperatively. PCS was also significantly higher in the LABFB group than OABFB at 24 months postoperatively. The preoperative QoL scores for both the laparoscopy and the open group were significantly lower than the age-matched general Norwegian population. EQ-5D median scores were significantly higher in the LABFB at all postoperative follow-up time points up to 12 months. The patients in the LABFB group also had a statistically significant increase in EQ-5D VAS compared to OABFB, at 1 and 12 months postoperatively (p = 0.005, and p = 0.037, respectively). CONCLUSION: QoL seems better in patients treated with LABFB than OABFB, particularly during the early months after surgery.


Asunto(s)
Aterosclerosis , Laparoscopía , Aterosclerosis/etiología , Encuestas Epidemiológicas , Humanos , Laparoscopía/efectos adversos , Dimensión del Dolor , Calidad de Vida , Encuestas y Cuestionarios
5.
Vasc Health Risk Manag ; 16: 87-97, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32256075

RESUMEN

BACKGROUND: Laparoscopic aortomesenteric bypass may be performed to treat the chronic mesenteric ischemia patients who are not suitable for endovascular treatment. This study presents an initial experience with a limited series of laparoscopic mesenteric artery revascularization for the treatment of mesenteric ischemia. METHODS: Chronic mesenteric ischemia (CMI) patients with previous unsuccessful endovascular treatment or with arterial occlusion and extensive calcification precluding safe endovascular treatment were offered laparoscopic mesenteric revascularization. From October 2015 until November 2018, nine patients with CMI underwent laparoscopic revascularization. In addition to demographic data and perioperative results of the treatment, graft patency was assessed with Duplex ultrasound at 1, 3, 6 and 12 months, and annually thereafter. A descriptive analysis of the data was performed. RESULTS: All bypasses were constructed with an 8 mm ring enforced expanded polytetrafluoroethylene graft in a retrograde fashion (from infrarenal aorta or iliac artery) to either superior mesenteric artery or splenic artery (2 cases). Median operation time was 356 mins (range 247-492 mins). Five patients had a history of unsuccessful endovascular treatment. Laparoscopic technical success was 78%, and the primary open conversion rate was 22%. All laparoscopic revascularization procedures remained patent after discharge during a median follow-up time of 26 months (range 18-49 months). The primary graft patency at 30 days was 78%. Primary assisted, and secondary graft patency was 78% and 100%, respectively. Median weight gain was 2 kg (range 2-18 kg), and all patients achieved relief from postprandial pain and nausea. No mortality was observed during the follow-up period. CONCLUSION: Laparoscopic aortomesenteric revascularization procedures for chronic mesenteric ischemia are feasible but require careful patient selection. These procedures should only be performed at referral centers by vascular surgeons with prior experience in laparoscopic vascular surgery.


Asunto(s)
Implantación de Prótesis Vascular , Laparoscopía , Arterias Mesentéricas/cirugía , Isquemia Mesentérica/cirugía , Oclusión Vascular Mesentérica/cirugía , Anciano , Implantación de Prótesis Vascular/efectos adversos , Enfermedad Crónica , Femenino , Oclusión de Injerto Vascular/diagnóstico por imagen , Oclusión de Injerto Vascular/fisiopatología , Oclusión de Injerto Vascular/cirugía , Humanos , Laparoscopía/efectos adversos , Masculino , Arterias Mesentéricas/diagnóstico por imagen , Arterias Mesentéricas/fisiopatología , Isquemia Mesentérica/diagnóstico por imagen , Isquemia Mesentérica/fisiopatología , Oclusión Vascular Mesentérica/diagnóstico por imagen , Oclusión Vascular Mesentérica/fisiopatología , Persona de Mediana Edad , Estudios Prospectivos , Reoperación , Circulación Esplácnica , Factores de Tiempo , Resultado del Tratamiento , Grado de Desobstrucción Vascular
6.
Tidsskr Nor Laegeforen ; 127(11): 1518-20, 2007 May 31.
Artículo en Noruego | MEDLINE | ID: mdl-17551557

RESUMEN

BACKGROUND: Laparoscopic aortic surgery (LAS), performed since 1993, has undergone a number of technical improvements during recent years. The published results are comparable with those for open surgery. The aim of this article is to present the method with a focus on technical details, and at the same time present our experience with this technique. MATERIAL AND METHODS: Eight patients with debilitating intermittent claudication were operated with a total laparoscopic aortofemoral bypass. Operations were performed through a transperitoneal retrorenal approach. Median age of the patients was 61 years (range 51-76). All patients had an aortoiliac occlusive disease of type D according to the Transatlantic Inter Society Consensus (TASC). Prior to the procedures an operation team followed a structured training programme that comprised using a training model and operating on pigs, and visited an international referral centre. RESULTS AND INTERPRETATION: All operations were successfully performed. No patient developed per- or post-operative complications. Median post-operative hospital stay was four days. LAS is a technically demanding procedure and it can be established through well targeted and carefully planned training.


Asunto(s)
Aorta Abdominal/cirugía , Arteriopatías Oclusivas/cirugía , Laparoscopía/métodos , Procedimientos Quirúrgicos Vasculares/métodos , Anciano , Animales , Aneurisma de la Aorta Abdominal/cirugía , Implantación de Prótesis Vascular/métodos , Competencia Clínica , Contraindicaciones , Arteria Femoral/cirugía , Humanos , Arteria Ilíaca/cirugía , Claudicación Intermitente/cirugía , Persona de Mediana Edad , Porcinos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...